The US Centers for Disease Control and Prevention updated its mask guidance on Tuesday to recommend that people who are fully vaccinated against COVID-19 resume wearing masks indoors in parts of the country with high levels of the virus.
More
The US Food and Drug Administration will soon add a warning label to Johnson & Johnson COVID-19 vaccines after about 100 people out of 12.8 million vaccinated patients developed Guillain-Barré syndrome, a largely recoverable neurological condition, according to multiple reports.
More
VOS.health, a digital mental health care platform that uses the latest technology, has raised another investment of 800,000 euros.
More
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans.
More
Minneapolis Mayor Jacob Frey announced Tuesday afternoon that the city’s mask-wearing mandate, that’s been in place since May 2020, is now lifted.
More
Centers for Disease Control and Prevention (CDC) announced on Thursday that people fully vaccinated against COVID-19 are allowed to engage in indoor and outdoor activities without the use of a mask or keeping to a six feet (1.8 m) social distance.
More
The COVID-19 variant B.1.617, first found in Maharashtra, India, has been named a variant of concern by the World Health Organization. But Soumya Swaminathan, the WHO’s chief scientist, said its classification is based on it being more transmissible.
More
A report circulated in recent weeks suggesting that a two-year-old girl died in Virginia after receiving the Pfizer COVID-19 vaccine during February clinical trials is “completely made up,” according to a statement to USA Today from the US Centers for Disease Control and Prevention.
More
Mucormycosis, or “black fungus”, is a potentially fatal infection affecting COVID-19 patients in India, where doctors believe it may be triggered by the use of steroids.
More
The Federal Trade Commission is sending 51,875 payments totaling more than $59 million to consumers who were victims of an allegedly deceptive scheme by Reckitt Benckiser Group and Indivior, Inc. to thwart lower-priced generic competition with the branded drug Suboxone. The average payment amount is $1,139. The payments will be mailed today.
More